Cyclin-dependent kinase 4 — Drug Target

All drugs that target Cyclin-dependent kinase 4 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Kinase Inhibitor

Marketed (1)

• Kisqali · Novartis · Kinase Inhibitor · Oncology
  Kisqali works by blocking a protein called cyclin-dependent kinase 4, which helps cancer cells grow and divide.